Agmatine Reduces Lipopolysaccharide-Mediated Oxidant Response via Activating PI3K/Akt Pathway and Up-Regulating Nrf2 and HO-1 Expression in Macrophages.
Macrophages are key responders of inflammation and are closely related with oxidative stress. Activated macrophages can enhance oxygen depletion, which causes an overproduction of reactive oxygen species (ROS) and leads to further excessive inflammatory response and tissue damage. Agmatine, an endogenous metabolite of L-arginine, has recently been shown to have neuroprotective effects based on its antioxidant properties. However, the antioxidant effects of agmatine in peripheral tissues and cells, especially macrophages, remain unclear. In this study we explored the role of agmatine in mediating antioxidant effects in RAW 264.7 cells and studied its antioxidant mechanism. Our data demonstrate that agmatine is an activator of Nrf2 signaling that markedly enhances Nrf2 nuclear translocation, increases nuclear Nrf2 protein level, up-regulates the expression of the Nrf2 downstream effector HO-1, and attenuates ROS generation induced by Lipopolysaccharide (LPS). We further demonstrated that the agmatine-induced activation of Nrf2 is likely through the PI3K/Akt pathway. LY294002, a specific PI3K/Akt inhibitor, abolished agmatine-induced HO-1 up-regulation and ROS suppression significantly. Inhibiting HO-1 pathway significantly attenuated the antioxidant effect of agmatine which the products of HO-1 enzymatic activity contributed to. Furthermore, the common membrane receptors of agmatine were evaluated, revealing that α2-adrenoceptor, I1-imidazoline receptor or I2-imidazoline receptor are not required by the antioxidant properties of agmatine. Taken together, our findings revealed that agmatine has antioxidant activity against LPS-induced ROS accumulation in RAW 264.7 cells involving HO-1 expression induced by Nrf2 via PI3K/Akt pathway activation.
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Jianshen
J
Chai
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Li
L
Luo
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Fengyan
F
Hou
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Xia
X
Fan
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Jing
J
Yu
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Wei
W
Ma
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Wangqi
W
Tang
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Xue
X
Yang
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Junyu
J
Zhu
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
Wenyuan
W
Kang
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Jun
J
Yan
State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
Huaping
H
Liang
Eur J Pharmacol. 2014 Jun 5;732:26-31
24657463
J Auton Nerv Syst. 1998 Oct 15;72(2-3):80-5
9851555
Brain Res. 2009 Jul 24;1281:64-70
19465011
Mol Pharm. 2010 Dec 6;7(6):2185-93
20831192
Nitric Oxide. 2011 Aug 1;25(2):153-60
21385624
Anadolu Kardiyol Derg. 2006 Mar;6(1):34-8
16524798
Pharmacol Res. 2013 Oct;76:132-48
23942037
CNS Drugs. 2007;21(11):885-900
17927294
PLoS One. 2015 Jun 15;10 (6):e0129676
26075390
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10584-9
10984543
Clin Exp Pharmacol Physiol. 2015 Jun 26;:null
26112210
J Biol Chem. 2002 Nov 8;277(45):42769-74
12198130
Life Sci. 2007 Jun 20;81(2):153-9
17532345
Biomed Res Int. 2014;2014:583736
25243152
Chemistry. 2014 Nov 3;20(45):14698-704
25224540
Chem Biol Interact. 2015 Dec 5;242:396-406
26577515
Eur J Pharm Sci. 2016 Apr 30;86:20-8
26944422
Biochem J. 2003 May 1;371(Pt 3):887-95
12570874
Ann N Y Acad Sci. 2003 Dec;1009:20-9
15028566
Free Radic Biol Med. 2012 Jul 1;53(1):172-81
22580125
Free Radic Biol Med. 2004 Aug 15;37(4):433-41
15256215
Eur J Pharmacol. 1986 May 13;124(1-2):167-70
3720837
Am J Physiol Cell Physiol. 2006 Apr;290(4):C1092-9
16291820
PLoS One. 2015 Nov 02;10 (11):e0141622
26524181
Biochemistry (Mosc). 2013 Feb;78(2):111-26
23581983
Brain Res. 2011 Feb 10;1373:48-54
21145312
Behav Brain Res. 2014 Mar 15;261:336-44
24406719
J Med Chem. 2016 Jan 28;59(2):756-62
26730678
Nutr Res Pract. 2015 Dec;9(6):579-85
26634045
Br J Pharmacol. 2005 Jul;145(6):800-10
15880142
Nat Med. 2002 Mar;8(3):240-6
11875494
Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):885-94
12699247
Free Radic Biol Med. 2000 Apr 15;28(8):1303-12
10889462
Trends Pharmacol Sci. 2000 May;21(5):187-93
10785653
Chem Res Toxicol. 2008 Jul;21(7):1484-94
18547064
Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):17-32
16529547
Neuropsychopharmacology. 2006 Aug;31(8):1722-32
16237388
Mol Neurobiol. 2015;51(3):1504-19
25084759
PLoS One. 2014 May 05;9(5):e94228
24796753
Biochem J. 2000 Jun 15;348 Pt 3:615-9
10839994
Mol Cell Biol. 2004 Aug;24(16):7130-9
15282312
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:143-50
24370459